$BRVE 3 SEC Filings

Filed On	Filing
14 Aug 2026	Form 3: Agarwala Vineeta, Director Holds 10,232,420 shares of Common Stock
06 Aug 2026	Form 3: Jiangsu Hengrui Pharmaceuticals Co., Ltd., 10% owner
05 Aug 2026	Form 3: Orbimed Advisors Llc, Director and 1 other Holds 1,102,739 shares of Common Stock
05 Aug 2026	Form 3: Ah Bio Fund IV, L.p., 10% owner and 3 others
05 Aug 2026	Form 3: Forbion Growth Opportunities Fund Iii Cooperatief U.a., 10% owner and 3 others Holds 588,126 shares of Common Stock
05 Aug 2026	Form 3: Lubner David Charles, Director No securities owned
05 Aug 2026	Form 3: Anderson Michele A., Chief Development Officer Holds 331,050 shares of Common Stock
05 Aug 2026	Form 3: Chimovits Erez, Director Holds 1,102,739 shares of Common Stock
05 Aug 2026	Form 3: Murdoch Travis, Director Holds 3,338,175 shares of Common Stock
05 Aug 2026	Form 3: Lohoff Tim, Director No securities owned
05 Aug 2026	Form 3: Malek David I, Director Holds 239,726 shares of Common Stock
05 Aug 2026	Form 3: Coloma Jason V, Director Holds 93,607 shares of Common Stock
05 Aug 2026	Form 3: Rickey James Paul, Chief Financial Officer Holds 91,324 shares of Common Stock
05 Aug 2026	Form 3: Viehbacher Christopher, Director Holds 150,338 shares of Common Stock
05 Aug 2026	Form 3: Bos Jasper, Director No securities owned

Comments